|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2000, Vol. 96, No. 5, pp. 1906-1913
NEOPLASIA
A carboxy-terminal deletion mutant of Notch1
accelerates lymphoid oncogenesis in E2A-PBX1
transgenic mice
Brian J. Feldman,
Tracy Hampton, and
Michael L. Cleary
From the Department of Pathology, Stanford University
Medical Center, Stanford, CA.
PBX1 is a proto-oncogene that plays important roles in
pattern formation during development. It was discovered as a fusion with the E2A gene after chromosomal translocations in a
subset of acute leukemias. The resulting E2a-Pbx1 chimeric proteins
display potent oncogenic properties that appear to require dimerization with Hox DNA binding partners. To define molecular pathways that may be
impacted by E2a-Pbx1, a genetic screen consisting of neonatal retroviral infection was used to identify genes that accelerate development of T-cell tumors in E2A-PBX1 transgenic mice.
Retroviral insertions in the Notch1 gene were observed in
88% of tumors arising with a shortened latency. Among these,
approximately half created a NotchIC allele,
encoding the intracellular, signaling portion of Notch1, suggesting a synergistic interaction between the Notch and E2a-Pbx1 pathways in oncogenesis. The remaining proviral insertions involving Notch1 occurred in a more 3' exon, resulting in truncating
mutations that deleted the carboxy-terminal region of
Notch1 containing negative regulatory sequences
(Notch1 C). In contrast to
NotchIC, forced expression of
Notch1 C in transgenic mice did not perturb
thymocyte growth or differentiation. However, mice transgenic for both
the E2A-PBX1 and Notch1 C genes
displayed a substantially shortened latency for tumor development compared with E2A-PBX1 single transgenic mice. These
studies reveal a novel mechanism for oncogenic activation of
Notch1 and demonstrate a collaborative relationship between
2 cellular oncogenes that also contribute to cell fate
determination during embryonic development.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Cullion, K. M. Draheim, N. Hermance, J. Tammam, V. M. Sharma, C. Ware, G. Nikov, V. Krishnamoorthy, P. K. Majumder, and M. A. Kelliher
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
Blood,
June 11, 2009;
113(24):
6172 - 6181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J.T. Staal and A. W. Langerak
Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia
Haematologica,
April 1, 2008;
93(4):
493 - 497.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fasseu, P. D. Aplan, M. Chopin, N. Boissel, J.-C. Bories, J. Soulier, H. von Boehmer, F. Sigaux, and A. Regnault
p16INK4A tumor suppressor gene expression and CD3{epsilon} deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis
Blood,
October 1, 2007;
110(7):
2610 - 2619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Sharma, J. A. Calvo, K. M. Draheim, L. A. Cunningham, N. Hermance, L. Beverly, V. Krishnamoorthy, M. Bhasin, A. J. Capobianco, and M. A. Kelliher
Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc
Mol. Cell. Biol.,
November 1, 2006;
26(21):
8022 - 8031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Carroll, W. Bu, D. Palmeri, S. Spadavecchia, S. J. Lynch, S. A. E. Marras, S. Tyagi, and D. M. Lukac
Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway
J. Virol.,
October 1, 2006;
80(19):
9697 - 9709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Priceputu, I. Bouallaga, Y. Zhang, X. Li, P. Chrobak, Z. S. Hanna, J. Poudrier, D. G. Kay, and P. Jolicoeur
Structurally Distinct Ligand-Binding or Ligand-Independent Notch1 Mutants Are Leukemogenic but Affect Thymocyte Development, Apoptosis, and Metastasis Differently
J. Immunol.,
August 15, 2006;
177(4):
2153 - 2166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Chiang, M. L. Xu, G. Histen, O. Shestova, M. Roy, Y. Nam, S. C. Blacklow, D. B. Sacks, W. S. Pear, and J. C. Aster
Identification of a Conserved Negative Regulatory Sequence That Influences the Leukemogenic Activity of NOTCH1.
Mol. Cell. Biol.,
August 1, 2006;
26(16):
6261 - 6271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Weng, J. M. Millholland, Y. Yashiro-Ohtani, M. L. Arcangeli, A. Lau, C. Wai, C. del Bianco, C. G. Rodriguez, H. Sai, J. Tobias, et al.
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Genes & Dev.,
August 1, 2006;
20(15):
2096 - 2109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Zhu, W.-L. Zhao, J.-F. Fu, J.-Y. Shi, Q. Pan, J. Hu, X.-D. Gao, B. Chen, J.-M. Li, S.-M. Xiong, et al.
NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis.
Clin. Cancer Res.,
May 15, 2006;
12(10):
3043 - 3049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Talora, S. Cialfi, C. Oliviero, R. Palermo, M. Pascucci, L. Frati, A. Vacca, A. Gulino, and I. Screpanti
Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis
Blood,
April 15, 2006;
107(8):
3313 - 3320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Leong and A. Karsan
Recent insights into the role of Notch signaling in tumorigenesis
Blood,
March 15, 2006;
107(6):
2223 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O'Neil, J. Calvo, K. McKenna, V. Krishnamoorthy, J. C. Aster, C. H. Bassing, F. W. Alt, M. Kelliher, and A. T. Look
Activating Notch1 mutations in mouse models of T-ALL
Blood,
January 15, 2006;
107(2):
781 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dumortier, R. Jeannet, P. Kirstetter, E. Kleinmann, M. Sellars, N. R. dos Santos, C. Thibault, J. Barths, J. Ghysdael, J. A. Punt, et al.
Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice
Mol. Cell. Biol.,
January 1, 2006;
26(1):
209 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Chiang, S. Hong, O. Shestova, W. Lee, M. Xu, W. S. Pear, and J. C. Aster
Synergistic Induction of T Cell Acute Lymphoblastic Leukemia by Functionally Distinct Mutations in NOTCH1.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
1200 - 1200.
[Abstract]
|
 |
|

|
 |

|
 |
 
S. A. Armstrong and A. T. Look
Molecular Genetics of Acute Lymphoblastic Leukemia
J. Clin. Oncol.,
September 10, 2005;
23(26):
6306 - 6315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hayward, K. Brennan, P. Sanders, T. Balayo, R. DasGupta, N. Perrimon, and A. M. Arias
Notch modulates Wnt signalling by associating with Armadillo/{beta}-catenin and regulating its transcriptional activity
Development,
April 15, 2005;
132(8):
1819 - 1830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Stasinopoulos, Y. Mironchik, A. Raman, F. Wildes, P. Winnard Jr., and V. Raman
HOXA5-Twist Interaction Alters p53 Homeostasis in Breast Cancer Cells
J. Biol. Chem.,
January 21, 2005;
280(3):
2294 - 2299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bijl, M. Sauvageau, A. Thompson, and G. Sauvageau
High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia
Genes & Dev.,
January 15, 2005;
19(2):
224 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Weng, A. A. Ferrando, W. Lee, J. P. Morris IV, L. B. Silverman, C. Sanchez-Irizarry, S. C. Blacklow, A. T. Look, and J. C. Aster
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Science,
October 8, 2004;
306(5694):
269 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Castilla, P. Perrat, N. J. Martinez, S. F. Landrette, R. Keys, S. Oikemus, J. Flanegan, S. Heilman, L. Garrett, A. Dutra, et al.
Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia
PNAS,
April 6, 2004;
101(14):
4924 - 4929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tsuji, H. Ishii-Ohba, H. Ukai, T. Katsube, and T. Ogiu
Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas
Carcinogenesis,
July 1, 2003;
24(7):
1257 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cooper, E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff
EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth
J. Virol.,
December 20, 2002;
77(2):
999 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jundt, I. Anagnostopoulos, R. Forster, S. Mathas, H. Stein, and B. Dorken
Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma
Blood,
May 1, 2002;
99(9):
3398 - 3403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Sykes and M. P. Kamps
Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins
Blood,
October 15, 2001;
98(8):
2308 - 2318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ronchini and A. J. Capobianco
Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic
Mol. Cell. Biol.,
September 1, 2001;
21(17):
5925 - 5934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Patel, M. Mukhtar, and R. J. Pomerantz
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis in Human Neuronal Cells
J. Virol.,
October 15, 2000;
74(20):
9717 - 9726.
[Abstract]
[Full Text]
|
 |
|
|
|